Skip to main content

Alliancebernstein L.P.

SEC CIK
0001109448
Latest filing
Aug 14, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Alliancebernstein L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
2,999,050
Value
$307.9M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Alliancebernstein L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,999,050$307.9M0.1%−4,799,079−61.5%ReducedHolders
Q1 20267,798,129$977.0M0.3%−4,653,808−37.4%ReducedHolders
Q4 202512,451,937$1.56B0.5%+6,926,031+125.3%AddedHolders
Q3 20255,525,906$740.1M0.2%+1,865,250+51.0%AddedHolders
Q2 20253,660,656$497.9M0.2%−168,803−4.4%ReducedHolders
Q1 20253,829,459$508.0M0.2%−15,139−0.4%ReducedHolders
Q4 20243,844,598$434.9M0.1%−318,536−7.7%ReducedHolders
Q3 20244,163,134$474.6M0.2%+962,082+30.1%AddedHolders
Q2 20243,201,052$332.6M0.1%−951,049−22.9%ReducedHolders
Q1 20244,152,101$471.9M0.2%−5,337,958−56.2%ReducedHolders
Q4 20239,490,059$1.04B0.4%−1,392,719−12.8%ReducedHolders
Q3 202310,882,778$1.05B0.4%+720,015+7.1%AddedHolders
Q2 202310,162,763$1.11B0.5%+911,942+9.9%AddedHolders
Q1 20239,250,821$936.7M0.4%−35,907−0.4%ReducedHolders
Q4 20229,286,728$1.02B0.5%−2,895,139−23.8%ReducedHolders
Q3 202212,181,867$1.18B0.6%−96,668−0.8%ReducedHolders
Q2 202212,278,535$1.33B0.6%−590,755−4.6%ReducedHolders
Q1 202212,869,290$1.52B0.6%−675,329−5.0%ReducedHolders
Q4 202113,544,619$1.91B0.7%−84,807−0.6%ReducedHolders
Q3 202113,629,426$1.61B0.6%+646,920+5.0%AddedHolders
Q2 202112,982,506$1.51B0.6%+84,274+0.7%AddedHolders
Q1 202112,898,232$1.55B0.7%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.